cvs caremark glp-1 lawsuit is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE CVS Caremark facing class action
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6






















:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)


